About Diabetic Retinopathy, Diabetic Macular Edema and current treatmentsDiabetic retinopathy is damage to the retina of the eyes caused by complications of diabetes mellitus and often resulting in loss of visual acuity and blindness. Macular edema of the eyes is often an early form of diabetic retinopathy that causes significant vision loss. Almost all Type 1 diabetics and more than 60% of Type 2 diabetics will develop retinopathy. There is no effective daily drug treatment for diabetic retinopathy other than general measures, such as controlling blood sugar, hypertension, blood lipids, etc. Due to the global diabetes epidemic, diabetic retinopathy is recognized as a high, unmet medical need that would benefit from having oral therapeutic options available. The only treatments available for macular edema now are laser therapy, injection or implantation of drugs into or around the eyeball (not approved in the US or Canada). To our knowledge, Optina(TM) is the only proposed oral treatment for this condition.About Optina(TM)

Researchers at Universidad Carlos III in Madrid (UC3M) have developed a system that can be built into virtual reality goggles that help patients with moderate visual impairment move around their surroundings.

MONROVIA, Calif., May 29, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it

PASADENA, Calif., May 25, 2012 /PRNewswire/ -- Children who are overweight or obese -- particularly older, non-Hispanic white girls -- are more likely to have a neurological disorder

Deaf-Blindness didn't stop with Helen Keller. People who experience combined vision and hearing losses are in need of highly specialized services.